Factors associated with the development of brain metastases

The risk of developing brain metastases after definitive treatment of locally advanced nonsmall cell lung cancer (NSCLC) is approximately 30%‐50%. The risk for patients with early stage disease is less defined. The authors sought to investigate this further and to study potential risk factors.

[1]  H. Choy,et al.  Phase III Study of Prophylactic Cranial Irradiation vs. Observation in Patients with Stage III Non–small-cell Lung Cancer: Neurocognitive and Quality of Life Analysis of RTOG 0214 , 2009 .

[2]  Z. Ram,et al.  The Expression of Three Genes in Primary Non–Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain , 2009, Clinical Cancer Research.

[3]  David J Sugarbaker,et al.  Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Loda,et al.  Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma , 2008, Cancer.

[5]  J. Nevins,et al.  Toward the individualization of lung cancer therapy , 2008, Cancer.

[6]  D. Gandara,et al.  Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited. , 2008, Archives of internal medicine.

[7]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[8]  Noriyuki Misaki,et al.  Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  V. Budach,et al.  Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. Collette,et al.  Prophylactic cranial irradiation in extensive small-cell lung cancer. , 2007, The New England journal of medicine.

[11]  N. Yamasaki,et al.  Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. , 2007, Lung cancer.

[12]  D. Larson,et al.  Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall‐cell lung cancer , 2007, Cancer.

[13]  Charles A Powell,et al.  Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. , 2007, Radiology.

[14]  Jeremy J. W. Chen,et al.  A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.

[15]  Julio Astudillo,et al.  Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. , 2006, The Lancet. Oncology.

[16]  S. Mukherjee,et al.  A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.

[17]  V. Rousson,et al.  Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. , 2005, The Annals of thoracic surgery.

[18]  A. Bezjak,et al.  Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? , 2005, Lung cancer.

[19]  C. Tseng,et al.  Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer , 2005, Journal of Neuro-Oncology.

[20]  J. Crowley,et al.  Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C. Kang,et al.  Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy. , 2005, The Annals of thoracic surgery.

[22]  P. Jänne,et al.  High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Dalphin,et al.  Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. , 2004, Lung cancer.

[24]  M. Cowles.  Modelling Survival Data in Medical Research (2nd ed.) (Book) , 2004 .

[25]  D. Collet.  Modelling Survival Data in Medical Research , 2004 .

[26]  H. Kato,et al.  A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. , 2004, The New England journal of medicine.

[27]  L. Voltolini,et al.  Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival? , 2003, The Journal of cardiovascular surgery.

[28]  J Audouin,et al.  Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. , 2002, Lung cancer.

[29]  A. Carretta,et al.  Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment , 2002, Cancer.

[30]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.

[31]  E. Ruffini,et al.  Stage I non-small cell lung carcinoma: really an early stage? , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  D. Harpole,et al.  Predicting the sites of metastases from lung cancer using molecular biologic markers. , 2001, The Annals of thoracic surgery.

[33]  T. Dipetrillo,et al.  Emergence of increased cerebral metastasis after high‐dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma , 2001, Cancer.

[34]  H. Wada,et al.  Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[35]  T. J. Robnett,et al.  Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  W. Yin,et al.  A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. , 2000, International journal of radiation oncology, biology, physics.

[37]  S. Gilbert,et al.  Who should follow up lung cancer patients after operation? , 2000, Annals of Thoracic Surgery.

[38]  Kenji Suzuki,et al.  Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma , 1999, Cancer.

[39]  H. Li,et al.  Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. , 1999, The Annals of thoracic surgery.

[40]  J P Pignon,et al.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. , 1999, The New England journal of medicine.

[41]  Xiong-zeng Zhu,et al.  Study of prognostic predictors for non-small cell lung cancer. , 1999, Lung cancer.

[42]  A H Russell,et al.  Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). , 1998, International journal of radiation oncology, biology, physics.

[43]  L. Gaspar,et al.  Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. , 1997, International journal of radiation oncology, biology, physics.

[44]  A. Brichet,et al.  Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. , 1996, The Annals of thoracic surgery.

[45]  D. Harpole,et al.  Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence , 1995, Cancer.

[46]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[47]  J. Cooper,et al.  Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. , 1991, International journal of radiation oncology, biology, physics.

[48]  H. Hansen,et al.  Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  R. Figlin,et al.  Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. , 1988, The New England journal of medicine.

[50]  L. Rubinstein,et al.  Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  D. Booser,et al.  Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer , 1984, Journal of Neuro-Oncology.

[52]  J. Cox,et al.  Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: correlation with survival. , 1983, International journal of radiation oncology, biology, physics.

[53]  W. Fry,et al.  Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. , 1981, The Annals of thoracic surgery.

[54]  P. Smets,et al.  Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design. , 1980, International journal of radiation oncology, biology, physics.

[55]  J. Cox,et al.  Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. , 1979, The American review of respiratory disease.

[56]  H. Hansen,et al.  Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma , 1974 .

[57]  Edward L. Melnick,et al.  Modeling Survival Data , 2011, International Encyclopedia of Statistical Science.

[58]  York Springer,et al.  Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .

[59]  N. Hanna,et al.  Vinorelbine Plus Cisplatin vs Observation in Resected Non–Small-Cell Lung Cancer , 2006 .

[60]  D. Galetta,et al.  Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[61]  M E Burt,et al.  Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.

[62]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[63]  Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. The Ludwig Lung Cancer Study Group. , 1987, Annals of surgery.

[64]  H. Hansen,et al.  Proceedings: Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. , 1974, Cancer.